Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Jun. 30, 2025
Current assets
Cash and cash equivalents	$ 227	$ 167
Receivables, net	671	821
Inventories, net	608	523
Prepaid expenses and other current assets	222	97
Total current assets	1,728	1,608
Property, plant and equipment, net of accumulated depreciation and amortization of $3,007 and $2,911, respectively	1,247	1,267
Operating lease right-of-use assets	368	333
Goodwill	1,231	1,229
Trademarks, net	502	502
Other intangible assets, net	54	64
Other assets	483	558
Total assets	5,613	5,561
Current liabilities
Notes and loans payable	307	4
Current operating lease liabilities	83	87
Accounts payable and accrued liabilities	1,957	1,828
Total current liabilities	2,347	1,919
Long-term debt	2,486	2,484
Long-term operating lease liabilities	341	305
Other liabilities	385	351
Deferred income taxes	19	20
Total liabilities	5,578	5,079
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of December 31, 2025 and June 30, 2025; and 120,890,241 and 122,694,263 shares outstanding as of December 31, 2025 and June 30, 2025, respectively	131	131
Additional paid-in capital	1,304	1,319
Retained earnings	190	432
Treasury stock, at cost: 9,851,220 and 8,047,198 shares as of December 31, 2025 and June 30, 2025, respectively	(1,591)	(1,404)
Accumulated other comprehensive net (loss) income	(159)	(157)
Total Clorox stockholders’ (deficit) equity	(125)	321
Noncontrolling interests	160	161
Total stockholders’ equity	35	482
Total liabilities and stockholders’ equity	$ 5,613	$ 5,561